Innogen's Innovation
Valianz, Valsartan and Amlodepine in 1
This volume of blood that transports the nutrients needed by the body exerts pressure in the veins and arteries. Too much pressure results into a condition known as hypertension. To address this condition, InnoGen Pharmaceuticals, Inc. is introducing a new anti-hypertensive medicine which is a combination of two proven molecules, an Angiotensin Receptor Blocker (ARB) and Calcium Channel Blocker (CCB).
This new product will enable physicians and patients to bridge the gap between EFFICACY and AFFORDABILITY in hypertension therapy. It will also improve the patients’ adherence to the medication, improving quality of life and ensuring success in therapy. Valianz is very affordable at P45 for the highest dosage and P29.50 for the lowest dosage
People with Hypertension must try their newest product, but please ask your doctor before taking it.
0 comments